News Artical

https://www.medgadget.com/2018/04/a...truction-interview-with-scott-dodson-ceo.html

Quick Copy of the only interesting items which is already known. 1 minute read.

Dodson: Physician and patient response has been very strong. AeroForm is currently available in over 160 hospitals and used by over 135 plastic surgeons across the United States. Many women aren’t aware of their breast reconstruction options and that technology has advanced as much as it has. We are working with the entire breast cancer care team, including oncologists, breast surgeons, radiation oncologists and plastic surgeons to bring more awareness to the benefits of our system and the significant impact it can have on women’s lives after cancer. The greatest testament to this advancement recently occurred when one of our physician advocates was diagnosed with the BRCA gene and opted for AeroForm Tissue Expander over saline for her own reconstruction.

Medgadget: What is the future for AirXpanders? Do you plan on further studies and are you developing new technologies?
Dodson: We anticipate significant growth and increased use of the AeroForm system in 2018 due to a number of factors. We are planning to introduce new sizes, which will allow women of most breast sizes the option to choose AeroForm in their reconstruction journey. We are also working to better understand and reach the entire breast cancer care team, as they all play a vital role in helping a patient decide on the best option for her care. Later this year, we also look forward to presenting new quality of life data related to the use of our device.